Summary
Phasmarhabditis thesamica n. sp., belonging to the family Rhabditidae, was isolated from the bodies of the invasive slug, Deroceras reticulatum in Georgia. Nematodes of this genus have never been recorded previously in Georgia. Phasmarhabditis thesamica n. sp. was characterised at morphological, morphometrical and molecular level. Females are 2052 (1863-2241) μm long, lateral fields consisting of three protruding central ridges and four incisions. The vulval opening is in the middle of the body. The tail is conical, long, tapering to a filiform tip, with prominent rod-shaped phasmids. The reproductive system is didelphic-amphidelphic. Males are 1301 (1123-1456) μm long, with an open peloderal bursa, which is supported by nine pairs of genital papillae 1 + 1 + 1/2 + 1 + 3, and two phasmids located close to tail tip. The molecular phylogeny of P. thesamica n. sp. inferred by using ITS, D2-D3 expansion domains of the 28S rRNA gene and the 18S rRNA gene revealed close relationships with P. clausiliiae, with high support.
Summary
A new species of entomopathogenic nematode, Steinernema borjomiense n. sp., was isolated from the body of the host insect, Oryctes nasicornis (Coleoptera: Scarabaeidae), in Georgia, in the territory of Borjomi-Kharagauli. Morphological characters indicate that the new species is closely related to species of the feltiae-group. The infective juveniles are characterised by the following morphological characters: body length of 879 (777-989) μm, distance between the head and excretory pore = 72 (62-80) μm, pharynx length = 132 (122-142) μm, tail length = 70 (60-80) μm, ratio a = 26.3 (23.0-29.3), H% = 45 (40-51), D% = 54 (47-59), E% = 102 (95-115), and lateral fields consisting of seven ridges (eight incisures) at mid-body. Steinernema borjomiense n. sp. was molecularly characterised by sequencing three ribosomal regions (the ITS, the D2-D3 expansion domains and the 18S rRNA gene) and the mitochondrial COI gene. Phylogenetic analyses revealed that S. borjomiense n. sp. differs from all other known species of Steinernema and is a member of the monticolum-group.
The effects of entomopathogenic nematodes EPN (Steinernematidae and Heterorhabditidae) and fungi EPF (Beauveria bassiana) strains were evaluated in laboratory assays against larvae of four xylophagous pests: the Asparagus moth Parahypopta caestrum, the European goat moth Cossus cossus, the pine longhorn Arhopalus syriacus and the black Buprestid Capnodis tenebrionis. Due to their biology and ethology, these insects may be included in the category of pests residing in cryptic habitats. The control of these species is considered difficult, due to the inability of chemical pesticides to penetrate the cryptic habitats and reach the targets. The pathogenicity of the entomopathogenic nematodes and fungi was tested in vitro against the pests. Two experimental models were considered and aimed to imitate the natural environment of the pests, in Petri dishes filled with plant material and inside wood galleries respectively. Main results showed that the majority of the tested strains of nematodes and fungi affected the insects' survival rate. Steinernema feltiae and B. bassiana caused the highest percentage of larval mortality (80-100%). Considering the lack of effective chemical control means, the microbial control of the xylophagous pests by EPN and EPF reveals promising perspectives. Nematodes and fungi are able to penetrate the cryptic habitats because they are living organisms and may be horizontally transmitted by infected hosts. The distribution of EPF as preventive control method and the injection of EPN suspensions to reach and infect the larvae inside the wood galleries can be a combined sustainable control system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.